Last updated: 2026-10-10 11:40:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
EVOGENE LTD. (EVGN) operates in the -- sector and is listed on NASDAQ. The stock is currently priced at $0.38, with a market capitalization of $6.30M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.35 to $1.49. This page covers its latest market performance, valuation, price trends and company information.
$6.30M | |
$0.39 | |
$203.90 | |
$0.35 | |
$0.40 | |
105.53K | |
1.49M | |
-- | |
$1.49 | |
$0.35 | |
-- | |
-- |
EVOGENE LTD. (EVGN) last closed at $0.40 as of 2026-10-09 23:30:00, unchanged from the previous close of $0.40.
During the latest regular trading session, EVGN traded between $0.35 and $203.90, with a volume of 105.53K shares. The closing price was near the lower end and near the lower end of its 52-week range.
Over the past seven days, EVOGENE LTD. (EVGN) moved from $0.44 to $0.38, representing a decline of 12.76% ($0.06).
The stock traded between $0.37 and $0.47 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 352.41 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
Position in Range: 2.5%
EVGN is currently trading at $0.38, placing it 2.5% of the way from its 52-week low of $0.35 to its 52-week high of $1.49. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
Evogene Ltd is a computational biology company targeting to revolutionize product development for life-science based industries, including human health, agriculture, and industrial applications. The company established its technology, the Computational Predictive Biology (CPB) platform. The CPB platform is designed to computationally discover and develop life-science products based on microbes, small molecules, and genetic elements as the core components for such products. It holds several subsidiaries utilizing the CPB platform for the development of human microbiome-based therapeutics, medical cannabis, ag-biologicals, ag-chemicals, seed traits, and ag-solutions for castor oil production. It generates maximum revenue from the industrial segment, followed by Agriculture.
| Employees | 52 |
| Exchange | NASDAQ |
| Company Website |
Eligible investors can buy real shares of EVOGENE LTD. (EVGN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.